| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |